Attard, G., Reid, A. H., A’Hern, R., Parker, C., Oommen, N. B., Folkerd, E., . . . de Bono, J. S. (2009). Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active in the Treatment of Castration-Resistant Prostate Cancer.
Citação norma ChicagoAttard, Gerhardt, et al. Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active in the Treatment of Castration-Resistant Prostate Cancer. 2009.
Citação norma MLAAttard, Gerhardt, et al. Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active in the Treatment of Castration-Resistant Prostate Cancer. 2009.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.